The evolving role of partial breast irradiation in early-stage breast cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23463089.
- Also identified by DOI 10.1245/s10434-013-2923-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Whole breast irradiation (WBI) over 5-7 weeks has long been considered standard adjuvant treatment after breast-conserving surgery. Recently the concept of irradiating the whole breast has been challenged by accelerated partial breast irradiation (APBI), which exclusively targets the lumpectomy site plus margin. We review the evidence supporting APBI from modern clinical trials, the pros and cons of various APBI techniques, and the controversies regarding the applicability of APBI to specific patient groups.
Medical subject headings
- Breast Neoplasms
- Carcinoma